Medicare Enrolled

Dr. Marc Dunn, M.D.

Pulmonary Disease · Royal Oak, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
30701 WOODWARD AVE STE 200, Royal Oak, MI 48073
2485482114
In practice since 2006 (20 years)
NPI: 1427002484 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dunn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dunn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dunn

Dr. Marc Dunn is a pulmonary disease specialist in Royal Oak, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dunn performed 2,346 Medicare services across 1,893 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dunn received a total of $14,313 from 48 pharmaceutical and/or device companies across 832 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dunn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 8% volume in MI $14,313 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,346
Medicare services
Top 8% in MI for pulmonary disease
1,893
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~117 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
852 $95 $144
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
375 $44 $109
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
359 $32 $79
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
348 $28 $109
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
170 $65 $115
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
122 $20 $68
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
73 $130 $204
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
26 $42 $64
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
21 $78 $136
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,313
Total received (2018-2024)
Avg $2,045/year across 7 years
Top 8% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
832
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,313 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,677
2023
$2,489
2022
$2,989
2021
$2,099
2020
$1,600
2019
$1,894
2018
$1,564

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$345
GlaxoSmithKline, LLC.
$283
Boehringer Ingelheim Pharmaceuticals, Inc.
$230
Regeneron Healthcare Solutions, Inc.
$149
Takeda Pharmaceuticals U.S.A., Inc.
$130
GENZYME CORPORATION
$98
Grifols USA, LLC
$96
Mylan Specialty L.P.
$87
United Therapeutics Corporation
$77
Actelion Pharmaceuticals US, Inc.
$70
ANI Pharmaceuticals, Inc.
$26
Pulmonx Corporation
$21
Merck Sharp & Dohme LLC
$19
Resmed Corp
$17
Hikma Pharmaceuticals USA
$16
Insmed, Inc.
$13
Top 3 companies account for 51.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,769
AstraZeneca Pharmaceuticals LP
$2,605
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,313
Mylan Specialty L.P.
$915
Grifols USA, LLC
$662
Regeneron Healthcare Solutions, Inc.
$634
Takeda Pharmaceuticals U.S.A., Inc.
$512
GENZYME CORPORATION
$458
Actelion Pharmaceuticals US, Inc.
$456
Circassia Pharmaceuticals Inc
$244
Inogen, Inc.
$230
United Therapeutics Corporation
$221
Electromed, Inc.
$193
Philips Electronics North America Corporation
$188
Genentech USA, Inc.
$186
Teva Pharmaceuticals USA, Inc.
$156
Insmed, Inc.
$138
Baxter Healthcare
$132
Pulmonx Corporation
$123
Sunovion Pharmaceuticals Inc.
$123
Harmony Biosciences LLC
$116
HARMONY BIOSCIENCES LLC
$77
Mallinckrodt Enterprises LLC
$69
Mallinckrodt Hospital Products Inc.
$65
Novartis Pharmaceuticals Corporation
$63
Gilead Sciences, Inc.
$59
Advanced Respiratory, Inc
$52
Shire North American Group Inc
$46
Tactile Systems Technology Inc
$43
IDORSIA PHARMACEUTICALS US INC
$42
Resmed Corp
$39
Covis Pharma GmBH
$33
Merck Sharp & Dohme LLC
$32
Merck Sharp & Dohme Corporation
$27
Inspire Medical Systems, Inc.
$27
ANI Pharmaceuticals, Inc.
$26
Axsome Therapeutics, Inc.
$25
La Jolla Pharmaceutical Company
$24
Mallinckrodt LLC
$24
PFIZER INC.
$22
Amgen Inc.
$21
Janssen Pharmaceuticals, Inc
$20
MAYNE PHARMA INC.
$19
Astellas Pharma US Inc
$18
Itamar Medical Inc
$17
Cumberland Pharmaceuticals, Inc.
$16
ADVANCED RESPIRATORY, INC
$16
Hikma Pharmaceuticals USA
$16
Top 3 companies account for 53.7% of all-time payments
Associated products mentioned in payments ›
(2928) NIV other · (7999) SRC Und · (8874) inCourage · ACTHAR · AIRSENSE · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CINQAIR · COMBIVENT RESPIMAT · Cresemba · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Esbriet · FASENRA · Flexitouch Plus · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · InogenOne · JARDIANCE · LONHALA MAGNAIR · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PANZYGA · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · Respiratoriy Care Undiv · Ryaltris · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · Vibativ · Wakix · WatchPATONE · Wellcentive Undiv · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for pulmonary disease in MI.

Looking for a pulmonary disease specialist in Royal Oak?
Compare pulmonary diseases in the Royal Oak area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
113
Per 100K population
8.9
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL ROYAL OAK
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dunn is a clinical cardiology specialist, with above-average Medicare volume (top 8% in MI), with low-engagement industry engagement in the top 8% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dunn experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dunn performed 852 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dunn receive payments from pharmaceutical companies?
Yes. Dr. Dunn received a total of $14,313 from 48 companies across 832 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dunn's costs compare to other pulmonary diseases in Royal Oak?
Dr. Dunn's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dunn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →